| Structure |
Chemical Name |
CAS |
MF |
![Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]-](/CAS/20200401/GIF/2356153-95-0.gif) |
Benzenesulfonamide, 4-[5-(4-methylphenyl)-2-oxido-3-(trifluoromethyl)-1H-pyrazol-1-yl]- |
2356153-95-0 |
C17H14F3N3O3S |
 |
2-Pyrrolidinecarbonitrile, 1-(2-aminoacetyl)-, hydrochloride (1:1), (2S)- |
913980-23-1 |
C7H12ClN3O |
 |
Lamivudine Impurity 7 |
147126-63-4 |
C14H24O4S |
 |
EsCitalopram EP Impurity I |
1370643-22-3 |
C20H21FN2O |
![(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine](/CAS/20200401/GIF/127017-42-9.gif) |
(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)-1-methylpiperidine |
127017-42-9 |
C21H25NO4 |
 |
Methylprednisolone Impurity 21 |
150899-33-5 |
C22H28O4 |
 |
Epinephrine Impurity 7 |
62322-82-1 |
C9H11NO3 |
 |
(trans)-4-((2-amino-4,6-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
 |
Fesoterodine Impurity 14 |
|
|
 |
Dexamethasone EP impurities E |
|
|
 |
(R)-N-((S)-2-aminobutanoyl)-3-(bromomethyl)hexanamide |
|
C11H21BrN2O2 |
 |
Empagliflozin Impurity 57(R,R) |
|
|
 |
Azacitidine Impurity 37 |
206269-46-7 |
C8H12N4O5 |
 |
Aripiprazole peroxide degradation Impurity (MW:303Da) |
|
|
 |
Pramipexole Impurity Reference |
|
|
 |
2,2'-(4,10-bis((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid Gd3+ |
|
|
![3-[4-(acetyloxymethyl)phenyl]-2-propenoic acid methyl ester](/CAS/20200515/GIF/100688-45-7.gif) |
3-[4-(acetyloxymethyl)phenyl]-2-propenoic acid methyl ester |
100688-45-7 |
C13H14O4 |
 |
Acetaminophen Impurity 14 |
1991204-56-8 |
C16H18N2O2 |
 |
Ketoconazole Impurity 7 |
172032-21-2 |
C11H12Cl2O3 |
 |
Rosuvastatin Impurity 59 |
|
|
 |
Losartan Impurity 12 |
727718-93-6 |
C22H22ClN9 |
 |
benzyl (2S)-2-amino-3-(4-methanesulfonylphenyl)propanoate hydrochloride |
1865726-28-8 |
C17H19NO4S |
 |
Glycopyrrolate Impurity 12 |
857353-41-4 |
C13H14O3 |
 |
(4S,4aR,5R,12aS)-4-(dimethylamino)-3,5,10,11,12a-pentahydroxy-6-methyl-1,12-dioxo-1,4,4a,5,12,12a-hexahydrotetracene-2-carboxamide |
4660-26-8 |
C22H22N2O8 |
 |
Regorafenib Impurity 38 |
|
|
 |
Cefazolin Impurity 28 |
|
|
 |
4-Isobutylacetophenone (Ibuprofen impurity) |
|
|
 |
Acarbose Impurity IV (JP) |
|
C13H21NO7 |
 |
Vonoprazan Impurity 57 |
|
|
 |
Tafluprost Impurity 9 |
2099033-66-4 |
C27H41NO8 |
 |
D(-)-AMETHOPTERIN |
51865-79-3 |
C20H22N8O5 |
 |
Oseltamivir Impurity 94 |
|
|
 |
Oseltamivir Impurity 82 |
|
|
 |
Oseltamivir Impurity 74 |
|
|
 |
Uridine, 5'-(2-methylpropanoate) (9CI) |
886538-48-3 |
C13H18N2O7 |
 |
Dapagliflozin Impurity 47 |
|
|
 |
Crisaborole Impurity 17 |
|
|
 |
Crisaborole Impurity 19 |
|
|
![1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]-](/CAS/20210305/GIF/2514695-40-8.gif) |
1,5-Pentanedione, 1-(2-fluorophenyl)-5-[(4S)-2-oxo-4-phenyl-3-oxazolidinyl]- |
2514695-40-8 |
C20H18FNO4 |
 |
4-ethoxy-3-(4-pyridyl)-3-buten-2-one |
88349-61-5 |
C11H13NO2 |
 |
1,3-dihydro-4-methyl-2H-1,5-benzodiazepin-2-one |
6276-48-8 |
C10H10N2O |
 |
(E)-2-methoxy-4-(prop-1-enyl)phenol |
5932-68-3 |
C10H12O2 |
![3-amino-5-[(methylthio)methyl]oxazolidin-2-one](/CAS/GIF/25517-72-0.gif) |
3-amino-5-[(methylthio)methyl]oxazolidin-2-one |
25517-72-0 |
C5H10N2O2S |
![Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI)](/CAS/20210305/GIF/107021-20-5.gif) |
Phosphonic acid, [[2-(6-amino-9H-purin-9-yl)propoxy]methyl]- (9CI) |
107021-20-5 |
C9H14N5O4P |
 |
Sitagliptin EP Impurity 7 |
|
|
 |
Sitagliptin EP Impurity H |
|
|
![7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]-](/CAS/20210305/GIF/2636673-48-6.gif) |
7-Benzofurancarboxamide, 4-amino-5-chloro-2,3-dihydro-3-hydroxy-N-[1-(3-methoxypropyl)-4-piperidinyl]- |
2636673-48-6 |
C18H26ClN3O4 |
 |
Beprostatin impurity 4 |
|
|
![cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole](/CAS/20180808/GIF/65621-78-5.gif) |
cis-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole |
65621-78-5 |
C17H16ClNO |
 |
methyl tosylcarbamate |
14437-03-7 |
C9H11NO4S |
![(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium](/CAS/20211123/GIF/786598-71-8.gif) |
(1R,2R,4S,5S,7s,9r)-9-butyl-9-methyl-7-((2-phenylacryloyl)oxy)-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium |
786598-71-8 |
C21H28NO3+ |
 |
(+)-2-Ethoxy-4-(N-3-Methyl-1(S)-(2-(1-Piperidinyl)Phenyl)-Butyl)Carbamoylmethyl) |
147770-06-7 |
C29H40N2O4 |
 |
4-Chloro-2-(chloromethyl)-3-Methyl Pyridine Hydrochloride |
152402-97-6 |
C7H8Cl3N |
 |
4-(3-Cyano-2-methylpropionyl)acetamilide |
42075-21-8 |
|
 |
Bimatoprost Impurity 11 |
|
|
 |
Bimatoprost Impurity 9 |
|
|
 |
Dolutegravir Impurity 18 |
|
|
![3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile](/CAS/20210111/GIF/380918-53-6.gif) |
3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile |
380918-53-6 |
C23H15N3O |
 |
Lenvatinib Impurity 33 |
|
|
 |
isopropyl 2-(2-oxopyrrolidin-1-yl)acetate |
1249080-59-8 |
C9H15NO3 |
 |
Pitavastatin Impurity 71 |
|
|
 |
Rosuvastatin EP Impurity M Sodium Salt |
|
|
 |
Furosemide impurity 8 |
|
|
 |
Febuxostat Impurity 108 |
|
|
 |
Flucloxacillin EP Impurity J |
|
|
![Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester](/CAS/20200611/GIF/1878175-77-9.gif) |
Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, mono[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethyl] ester |
1878175-77-9 |
C17H23N10O4P |
![Acetic acid, 2-[[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]amino]-2-oxo-, ethyl ester](/CAS/20200611/GIF/480450-85-9.gif) |
Acetic acid, 2-[[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]amino]-2-oxo-, ethyl ester |
480450-85-9 |
C21H31N5O5S |
![3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)-](/CAS/20211123/GIF/1193817-52-5.gif) |
3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)- |
1193817-52-5 |
C33H35FN2O7 |
 |
Hexanoic acid, 3-formyl-, ethyl ester |
54374-02-6 |
C9H16O3 |
 |
D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)- |
154877-92-6 |
C9H16O5 |
 |
Linagliptin Dimer impurity (N-C-C-C Dimer)Q: What is
Linagliptin Dimer impurity (N-C-C-C Dimer) Q: What is the CAS Number of
Linagliptin Dimer impurity (N-C-C-C Dimer) |
2463617-49-2 |
C51H56N16O4 |
![Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-](/CAS/20210111/GIF/906673-43-6.gif) |
Benzoic acid, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]- |
906673-43-6 |
C14H11BO5 |
 |
Benzenemethanamine, α,α'-sulfonylbis(methylene)bis[3-ethoxy-4-methoxy- |
2417213-71-7 |
C22H32N2O6S |
![1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-](/CAS/20210111/GIF/2138805-26-0.gif) |
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
![1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo-](/CAS/20210111/GIF/1651211-78-7.gif) |
1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1,N3-bis(2,3-dihydroxypropyl)-2,4-diiodo- |
1651211-78-7 |
C19H27I2N3O9 |
 |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
 |
(E)-1-(4-(2-carboxyvinyl)benzyl)-1H-imidazole 3-oxide |
|
|
 |
Aprepitant impurity 2 |
|
|
 |
Aprepitant impurity 4 |
|
|
 |
Vonoprazan Impurity B-2 |
|
|
 |
2-(Cyanomethylthio)acetic acid |
55817-29-3 |
C4H5NO2S |
 |
2(1H)-Pyridinone, 1-(3-aminophenyl)-5,6-dihydro-3-(4-morpholinyl)- |
2437650-75-2 |
C15H19N3O2 |
 |
4(1H)-Pyridinone, 1-(6-methoxy-1H-benzimidazol-2-yl)-2,3,5-trimethyl- |
2512216-37-2 |
C16H17N3O2 |
 |
Budesonide Impurity 31 |
|
|
 |
Budesonide Impurity 23 |
|
|
![Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime]](/CAS/GIF/119699-81-9.gif) |
Erythromycin, 6-O-Methyl-2',4'-Bis-O-(Trimethylsilyl)-, 9-[O-(1-Methoxy-1-Methylethyl)Oxime] |
119699-81-9 |
C48H94N2O14Si2 |
 |
(R)-8-(3-aminopiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-7-(3-oxobutyl)-3,7-dihydro-1H-purine-2,6-dione |
|
|
 |
Isavuconazole Impurity 37 |
|
|
 |
"mixture of 2-amino-9-[[2-(hydroxymethoxy) ethoxy]methyl]-1,9-dihydro-6H-purin-6-one and 2-amino-9-[[2-(hydroxyethoxy)methoxy]methyl]-1,9- dihydro-6H-purin-6-one," |
|
|
![N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide](/CAS/20210305/GIF/1375004-39-9.gif) |
N-((R)-1-(((R)-3-methyl-1-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
1375004-39-9 |
C29H39BN4O4 |
 |
(S)-1-(2-(((1r,3R,5S,7S)-3,5-dihydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile |
|
|
 |
Mannitol EP impurity B |
|
|
 |
Mannitol EP impurity A |
|
|
 |
Peramivir Amino Carboxylic Isomerism Impurity |
|
|
 |
Peramivir Chlorinated Impurity |
|
|
 |
Brivaracetam Impurity 999 |
|
|
 |
Dasatinib impurity 48 |
|
|
 |
Pemetrexed Impurity 120 |
|
|
 |
Ticagrelor Impurity 101 |
|
|
![4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane](/) |
4-tosyl-1,4,8,11-tetraazabicyclo[9.3.1]pentadecane |
|
|